ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 55 filers reported holding ATHIRA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,690,501 | -31.5% | 4,797,278 | 0.0% | 0.32% | -21.2% |
| Q2 2023 | $14,151,970 | +18.0% | 4,797,278 | 0.0% | 0.41% | +15.8% |
| Q1 2023 | $11,993,195 | -21.1% | 4,797,278 | 0.0% | 0.35% | -17.1% |
| Q4 2022 | $15,207,371 | +6.7% | 4,797,278 | 0.0% | 0.43% | +3.1% |
| Q3 2022 | $14,248,000 | -2.6% | 4,797,278 | 0.0% | 0.41% | -9.6% |
| Q2 2022 | $14,632,000 | -68.4% | 4,797,278 | +40.0% | 0.46% | -50.5% |
| Q1 2022 | $46,250,000 | -48.2% | 3,425,916 | -50.0% | 0.93% | +34.4% |
| Q4 2021 | $89,280,000 | +177.8% | 6,851,832 | +100.0% | 0.69% | +47.5% |
| Q3 2021 | $32,135,000 | -54.2% | 3,425,916 | -50.0% | 0.47% | +2.4% |
| Q2 2021 | $70,162,000 | +11.3% | 6,851,832 | +100.0% | 0.46% | -42.8% |
| Q1 2021 | $63,037,000 | -40.9% | 3,425,916 | +10.0% | 0.80% | -30.4% |
| Q4 2020 | $106,682,000 | +85.5% | 3,114,805 | 0.0% | 1.14% | +36.5% |
| Q3 2020 | $57,499,000 | – | 3,114,805 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |